Pharmacology Exam 3: Chapter 30 Skeletal
Muscle, Bone, and Joint Disorder Drugs Updated
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
Intervention for Readiness for Inhanced Fluid Balance related to Uric Acid Inhibitors -
ANSWERS--instruct the patient to take the drug upon arising in the morning, with 6 to 8
ounces of water, and remain in an upright position
-Discuss ways to provide adequate fluids and remind the patient frequently of the
importance of increasing fluid intake
-it may be necessary to administer intravenous (IV) fluids
Intervention for Gastric Distress related to Bone Resorption Inhibitor - ANSWERS--
instruct the patient to take the drug upon arising in the morning, with 6 to 8 ounces of
water, and remain in an upright position
-remain upright (avoid lying down) for at least 30 minutes after taking the drug
What should be avoided when admin of Etidronate? - ANSWERS-it should not be
administered within 2 hours of food, vitamin and mineral supplements, or antacids
Intervention for Risk for Injury related to Musckuloskeletal Disorder Drugs - ANSWERS-
-cause drowsiness
-pain or deformity may hamper mobility
-teach the family to monitor the patient carefully before allowing the patient to ambulate
alone
-If drowsiness does occur, assistance with ambulatory activities is necessary
, -bed rest require position changes and skin care every 2 hours
-osteoporosis may require a brace or corset when out of bed
Intervention for Risk for Allergic Response related to more Toxic Musculoskeletal
Disorder Drugs - ANSWERS--closely monitored for the development of adverse
reactions
-Should anaphylactic shock occur start resuscitative measures as emergency personnel
are notified
Musculoskeletal Disorder Drugs Evaluation - ANSWERS-• Patient improves fluid
balance.
• GI comfort is maintained.
• No evidence of injury is seen.
• Allergic response is minimized.
skeletal muscle relaxants action - ANSWERS-ability to relieve acute painful
musculoskeletal conditions may be because of their sedative action
skeletal muscle relaxants uses - ANSWERS-used in various acute painful
musculoskeletal conditions, such as muscle strains and back pain
skeletal muscle relaxants adverse reactions - ANSWERS-Drowsiness
Diazepam adverse reactions - ANSWERS-drowsiness, sedation, sleepiness, lethargy,
constipation or diarrhea, bradycardia or tachycardia, and rash
Rheumatoid arthritis (RA) - ANSWERS-white blood cells are mobilized and lodge in the
joints, causing swelling, pain, and inflammation
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) - ANSWERS--have
properties to produce immunosuppression, which in turn decreases the body's
autoimmune response
Muscle, Bone, and Joint Disorder Drugs Updated
Exam 2026 WITH Recent Newest Verified And
Well Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions) ALREADY
GRADED A+||NEWEST VERSION Of The Exam
Guarantee Pass!!
Intervention for Readiness for Inhanced Fluid Balance related to Uric Acid Inhibitors -
ANSWERS--instruct the patient to take the drug upon arising in the morning, with 6 to 8
ounces of water, and remain in an upright position
-Discuss ways to provide adequate fluids and remind the patient frequently of the
importance of increasing fluid intake
-it may be necessary to administer intravenous (IV) fluids
Intervention for Gastric Distress related to Bone Resorption Inhibitor - ANSWERS--
instruct the patient to take the drug upon arising in the morning, with 6 to 8 ounces of
water, and remain in an upright position
-remain upright (avoid lying down) for at least 30 minutes after taking the drug
What should be avoided when admin of Etidronate? - ANSWERS-it should not be
administered within 2 hours of food, vitamin and mineral supplements, or antacids
Intervention for Risk for Injury related to Musckuloskeletal Disorder Drugs - ANSWERS-
-cause drowsiness
-pain or deformity may hamper mobility
-teach the family to monitor the patient carefully before allowing the patient to ambulate
alone
-If drowsiness does occur, assistance with ambulatory activities is necessary
, -bed rest require position changes and skin care every 2 hours
-osteoporosis may require a brace or corset when out of bed
Intervention for Risk for Allergic Response related to more Toxic Musculoskeletal
Disorder Drugs - ANSWERS--closely monitored for the development of adverse
reactions
-Should anaphylactic shock occur start resuscitative measures as emergency personnel
are notified
Musculoskeletal Disorder Drugs Evaluation - ANSWERS-• Patient improves fluid
balance.
• GI comfort is maintained.
• No evidence of injury is seen.
• Allergic response is minimized.
skeletal muscle relaxants action - ANSWERS-ability to relieve acute painful
musculoskeletal conditions may be because of their sedative action
skeletal muscle relaxants uses - ANSWERS-used in various acute painful
musculoskeletal conditions, such as muscle strains and back pain
skeletal muscle relaxants adverse reactions - ANSWERS-Drowsiness
Diazepam adverse reactions - ANSWERS-drowsiness, sedation, sleepiness, lethargy,
constipation or diarrhea, bradycardia or tachycardia, and rash
Rheumatoid arthritis (RA) - ANSWERS-white blood cells are mobilized and lodge in the
joints, causing swelling, pain, and inflammation
DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDs) - ANSWERS--have
properties to produce immunosuppression, which in turn decreases the body's
autoimmune response
